Treatment Patterns, Outcomes and Costs Among Elderly Patients with Chronic Myeloid Leukaemia: A Population-Based Analysis

Author： Joseph Menzin  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.11, 2004-01, pp. : 737-746

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: A population-based analysis

By Shen Chan   Shih Ya-Chen Tina   Xu Ying   Yao James C.  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 2039-2049

Blackwell Publishing

Access to resources Recommend Favorite

Acute Myeloid Leukaemia: Optimising Treatment in Elderly Patients

By Jackson G.H.   Taylor P.R.A.  

Drugs & Aging, Vol. 19, Iss. 8, 2002-01 ,pp. : 571-581

Adis International

Access to resources Recommend Favorite

Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia

By Darkow Theodore  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 481-496

Adis International

Access to resources Recommend Favorite

Dasatinib Treatment for Imatinib Resistant or Intolerant Patients with Chronic Myeloid Leukaemia

By Li J   Xu G   Yu S   He L   Guo L  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 337-347

Field House Publishing

Access to resources Recommend Favorite

Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre-Dialysis Chronic Kidney Disease in Managed Care Organisations

By Mei Sheng Duh  

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 969-976

Adis International

Access to resources Recommend Favorite